Related Experiment Video
Updated: May 10, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Association of blood groups with prognosis in acute coronary syndrome
Insights
Rh-positive blood groups are linked to increased mortality in acute coronary syndrome (ACS) patients. This finding highlights blood type as a significant prognostic factor in ACS, warranting further investigation in cardiovascular disease research.
Area of Science:
- Cardiology
- Hematology
- Prognostic Biomarkers
Background:
- Prognostic factors for acute coronary syndromes (ACS) are well-documented.
- Limited data exists on the influence of blood groups on ACS prognosis.
Purpose of the Study:
- To investigate the impact of ABO and Rh (D antigen) blood group status on the prognosis of patients with ACS.
Main Methods:
- Analysis of 418 consecutive hospitalized ACS patients with a follow-up of 2075 ±794 days.
- Primary endpoint was all-cause mortality.
- Statistical analysis included subgroups based on ABO, Rh factor, and specific antigen presence (A, B, D).
Main Results:
- Rh-positive blood group was identified as an independent predictor of mortality in ACS patients (Hazard Ratio: 7.758, P=0.007).
- Kaplan-Meier analysis showed a significantly higher 7-year mortality in Rh-positive individuals (22.7%) compared to Rh-negative individuals (10%, P=0.014).
- No other ABO or Rh subgroup comparisons reached statistical significance.
Conclusions:
- Rh-positive blood group status is an independent predictor of mortality in patients diagnosed with ACS.
- Blood group, specifically Rh factor, may play a role in ACS outcomes.
Introduction:
Multiple factors that affect the prognosis of acute coronary syndromes (ACS) have been identified. There are scarce data on the effect of the blood group on prognosis in this patient group.
Objectives:
We investigated the effect of ABO and Rh (D antigen) status on the prognosis of ACS.
Patients And Methods:
A group of 418 consecutive hospitalized patients with ACS were analyzed. The follow‑up period was 2075 ±794 days. The primary endpoint was all‑cause mortality. A statistical analysis was performed for the following subgroups: ABO blood group, ABO blood group including Rhesus (Rh) factor (D antigen), Rh‑positive vs. Rh‑negative blood group, O blood group vs. non‑0 blood group, blood group with vs. without the B antigen, and blood group with vs. without the A antigen.
Results:
A total of 348 patients (83.25%) were Rh-positive, while 70 (16.75%) were Rh‑negative. The Kaplan-Meier survival plots showed 7‑year mortality of 22.7% in patients with blood groups with Rh antigen and of 10% in patients without Rh antigen (P = 0.014). Other comparisons were not statistically significant. A multivariable Cox proportional hazards model identified blood group with D antigen as an independent predictor of mortality (hazard ratio, 7.758; 95% confidence interval, 1.748-34.417; P = 0.007).
Conclusions:
Of all blood groups, only the Rh‑positive blood group was an independent predictor of mortality in patients with ACS.
Related Concept Videos
The ABO Blood Group
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Acute Coronary Syndrome III: Diagnostic Studies
Blood Types
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
